Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Byggfakta in connection with the public takeover offer from Giant BidCo
Mandate

Vinge advises Byggfakta in connection with the public takeover offer from Giant BidCo

January 05, 2024 EU, Competition and Regulatory Banking and Finance

Vinge has advised Byggfakta Group Nordic HoldCo AB (publ) in connection with a public takeover offer provided by Stirling Square, TA Associates and Macquarie Capital, through Giant BidCo, to the shareholders of Byggfakta. The offer price is SEK 46 per share and values Byggfakta to approximately SEK 10.1 billion.

Vinge’s team primarily consists of Anders Strid and Edin Agic as well as Anna Palmérus (EU & Antitrust) and Albert Wållgren (Banking & Finance).

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

 Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026